For patients with acute idiopathic/MS-associated optic neuritis (ON), the only predictor of long-term visual acuity (VA; 1 year) is baseline VA.1 Because prediction models were developed with Optic Neuritis Treatment Trial (ONTT) data,2 external validation is needed
The Optic Neuritis Treatment Trial (ONTT) provided a vast amount of knowledge with regard to ON in a...
OBJECTIVE: Optic neuritis (ON) is inflammation of the optic nerve that generally leads to transient ...
In most parts of the world acute demyelinating optic neuritis (ON) is the most common cause of unila...
Background: Short-term outcomes of optic neuritis (ON) have been well characterized. Limited data ex...
Background Multiple sclerosis ( MS) is a common disease with considerable risk for disability. Optic...
BackgroundPredicting long-term visual outcomes and axonal loss following acute optic neuritis (ON) i...
To evaluate visual field abnormalities 1- 5 and 10 years after the Optic Neuritis Treatment Trial (O...
To evaluate visual field abnormalities after an episode of optic neuritis in Optic Neuritis Treatmen...
Although patients with acute optic neuritis (ON) recover high-contrast visual acuity (HCVA) to 20/40...
It has been reported that patients with acute optic neuritis (ON) have good visual recovery, with re...
Background: To identify the factors associated with visual prognosis for functional and structural o...
Optic Neuritis Treatment Trial (ONTT) patients have been followed for > 10 years in order to evaluat...
Just over a decade ago, clinical trials for multiple sclerosis (MS) did not include visual outcomes....
The study aimed to investigate the efficacy of intravenous optic neuritis treatment trial (ONTT) reg...
After acute optic neuritis, residual visual defects, suggestive of permanent demyelination or axonal...
The Optic Neuritis Treatment Trial (ONTT) provided a vast amount of knowledge with regard to ON in a...
OBJECTIVE: Optic neuritis (ON) is inflammation of the optic nerve that generally leads to transient ...
In most parts of the world acute demyelinating optic neuritis (ON) is the most common cause of unila...
Background: Short-term outcomes of optic neuritis (ON) have been well characterized. Limited data ex...
Background Multiple sclerosis ( MS) is a common disease with considerable risk for disability. Optic...
BackgroundPredicting long-term visual outcomes and axonal loss following acute optic neuritis (ON) i...
To evaluate visual field abnormalities 1- 5 and 10 years after the Optic Neuritis Treatment Trial (O...
To evaluate visual field abnormalities after an episode of optic neuritis in Optic Neuritis Treatmen...
Although patients with acute optic neuritis (ON) recover high-contrast visual acuity (HCVA) to 20/40...
It has been reported that patients with acute optic neuritis (ON) have good visual recovery, with re...
Background: To identify the factors associated with visual prognosis for functional and structural o...
Optic Neuritis Treatment Trial (ONTT) patients have been followed for > 10 years in order to evaluat...
Just over a decade ago, clinical trials for multiple sclerosis (MS) did not include visual outcomes....
The study aimed to investigate the efficacy of intravenous optic neuritis treatment trial (ONTT) reg...
After acute optic neuritis, residual visual defects, suggestive of permanent demyelination or axonal...
The Optic Neuritis Treatment Trial (ONTT) provided a vast amount of knowledge with regard to ON in a...
OBJECTIVE: Optic neuritis (ON) is inflammation of the optic nerve that generally leads to transient ...
In most parts of the world acute demyelinating optic neuritis (ON) is the most common cause of unila...